Dewpoint Therapeutics Raises $77M Series B Financing to Advance the Development of Drugs That Target Biomolecular Condensates

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2GozoaF
via IFTTT